Systemic Sarcoidosis After Polycaprolactone Fillers Successfully Treated with Upadacitinib

This publication has 9 references indexed in Scilit:

• A review of sarcoidosis etiology, diagnosis and treatment
  Frontiers in Medicine, 2025
• The New Frontier of JAK Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks
  Journal of Cosmetic Dermatology, 2024
• Upadacitinib for Treatment of Granulomatous Cheilitis
  JAMA Dermatology, 2024
• Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib
  Dermatology and Therapy, 2024
• Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
  Nature Communications, 2022
• Cutaneous and Ganglion Sarcoidosis Induced by Polycaprolactone Facial Filler: A New Expression of ASIA Syndrome?
  European Journal of Case Reports in Internal Medicine, 2021
• Granulomes après injection d’Ellansé®, résolutifs sous méthotrexate
  Annales de Dermatologie et de Vénéréologie, 2020
• Polycaprolactone‐based dermal filler complications: A retrospective study of 1111 treatments
  Journal of Cosmetic Dermatology, 2020
• Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis
  New England Journal of Medicine, 2018